Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
walnut oil
- Development stage
- Unknown
- Lead developer
- Shiraz University of Medical Sciences
- Administration
- Oral
01
Overview
Walnut oil is a natural botanical oil extracted from the seeds of the English walnut (*Juglans regia*). It is highly enriched in polyunsaturated fatty acids (PUFAs), particularly linoleic acid and alpha-linolenic acid (ALA), an omega-3 fatty acid. Walnut oil is primarily utilized as a dietary supplement and nutraceutical for its antioxidant, anti-inflammatory, and lipid-lowering properties. Clinical studies have demonstrated its efficacy in improving lipid profiles in patients with hyperlipidemia and type 2 diabetes, significantly reducing total cholesterol, low-density lipoprotein (LDL), and triglycerides. In preclinical research, walnut oil has also shown potential cardioprotective effects, such as mitigating letrozole-induced cardiotoxicity in zebrafish models by preventing the downregulation of G-protein coupled estrogen receptor 1 (GPER1) and modulating nitric oxide synthase 1 (NOS1) expression.
- Other names
- Juglans regia seed oilPersian walnut oil
02
Targets
PXR (Pregnane X receptor)NOS1 (nNOS)FXR (Farnesoid x-activated receptor)SCD1 (Stearoyl-CoA desaturase 1)GPER1 (G protein-coupled estrogen receptor 1)ASIC (ASIC family)NR1H3 (Liver X receptor beta)
Beyond the preview
Go deeper on walnut oil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on walnut oil.